These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo. Akiba H; Takeda K; Kojima Y; Usui Y; Harada N; Yamazaki T; Ma J; Tezuka K; Yagita H; Okumura K J Immunol; 2005 Aug; 175(4):2340-8. PubMed ID: 16081804 [TBL] [Abstract][Full Text] [Related]
28. ICOS ligand costimulation is required for T-cell encephalitogenicity. Sporici RA; Beswick RL; von Allmen C; Rumbley CA; Hayden-Ledbetter M; Ledbetter JA; Perrin PJ Clin Immunol; 2001 Sep; 100(3):277-88. PubMed ID: 11513541 [TBL] [Abstract][Full Text] [Related]
29. [Evolutionary development of the immunoglobulins super family]. Galaktionov VG Izv Akad Nauk Ser Biol; 2004; (2):133-45. PubMed ID: 15131974 [TBL] [Abstract][Full Text] [Related]
30. Cutting edge: monovalency of CD28 maintains the antigen dependence of T cell costimulatory responses. Dennehy KM; Elias F; Zeder-Lutz G; Ding X; Altschuh D; Lühder F; Hünig T J Immunol; 2006 May; 176(10):5725-9. PubMed ID: 16670276 [TBL] [Abstract][Full Text] [Related]
31. Cooperation between 4-1BB and ICOS in the immune response to influenza virus revealed by studies of CD28/ICOS-deficient mice. Vidric M; Suh WK; Dianzani U; Mak TW; Watts TH J Immunol; 2005 Dec; 175(11):7288-96. PubMed ID: 16301634 [TBL] [Abstract][Full Text] [Related]
32. Protective Role of ICOS and ICOS Ligand in Corneal Transplantation and in Maintenance of Immune Privilege. Kunishige T; Taniguchi H; Terada M; Akiba H; Yagita H; Abe R; Hori J Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6815-6823. PubMed ID: 28002569 [TBL] [Abstract][Full Text] [Related]
33. IMGT Colliers de Perles and IgSF domain standardization for T cell costimulatory activatory (CD28, ICOS) and inhibitory (CTLA4, PDCD1 and BTLA) receptors. Garapati VP; Lefranc MP Dev Comp Immunol; 2007; 31(10):1050-72. PubMed ID: 17391759 [TBL] [Abstract][Full Text] [Related]
34. Enhanced CD40 and ICOSL expression on dendritic cells surface improve anti-tumor immune responses; effectiveness of mRNA/chitosan nanoparticles. Daneshmandi S; Pourfathollah AA; Forouzandeh-Moghaddam M Immunopharmacol Immunotoxicol; 2018 Oct; 40(5):375-386. PubMed ID: 30265161 [No Abstract] [Full Text] [Related]
35. Differential expression of inducible costimulator-ligand splice variants: lymphoid regulation of mouse GL50-B and human GL50 molecules. Ling V; Wu PW; Miyashiro JS; Marusic S; Finnerty HF; Collins M J Immunol; 2001 Jun; 166(12):7300-8. PubMed ID: 11390480 [TBL] [Abstract][Full Text] [Related]
36. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation. Zhou XY; Yashiro-Ohtani Y; Nakahira M; Park WR; Abe R; Hamaoka T; Naramura M; Gu H; Fujiwara H J Immunol; 2002 Apr; 168(8):3847-54. PubMed ID: 11937538 [TBL] [Abstract][Full Text] [Related]
37. Crystallization and preliminary X-ray diffraction analysis of a single variable domain of the immunoglobulin superfamily in amphioxus, Amphi-IgSF-V. Jiang B; Liu Y; Chen R; Wang Z; Tariq M; Xia C Acta Crystallogr F Struct Biol Commun; 2014 Aug; 70(Pt 8):1072-5. PubMed ID: 25084385 [TBL] [Abstract][Full Text] [Related]